Pharmacy Benefit Management

From Specialty Pharmacy News - In the second time in as many months, a partnership between a national health insurer and Fresenius Medical Care North America (FMCNA) that’s focused on end-stage renal disease (ESRD) has been announced. Humana Inc. is partnering with FMCNA to improve the care of its Medicare Advantage (MA) members with the condition, which can be very complex to manage. Read more

From Drug Benefit News - California PBMs would be required to get state licenses and to disclose their rebates as part of a bill under consideration by California lawmakers. The proposal, which comes at a time when PBMs’ roles are under increased scrutiny both on the state level and nationally, also would develop requirements for PBMs to meet in order to be licensed. PBMs now are not regulated at all in California. “This lack of oversight coupled… Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - April 14, 2016
In the latest squabble between drugstores and PBMs, the National Community Pharmacists Association (NCPA) on April 1 issued a letter to CMS Deputy Director Cynthia Tudor asserting that Medicare Part D plans and PBMs are not complying with a federal requirement to use drug pricing standards that “...
By Angela Maas - March 30, 2016
As high drug prices continue to make headlines and draw congressional ire, hepatitis C drugs and “Mr. Wu-Tang” Martin Shkreli seem to be getting a reprieve as focus turns to the prostate cancer drug Xtandi. On March 28, 12 members of Congress sent a letter to HHS Sec. Sylvia Burwell and Francis...
By Lauren Flynn Kelly - March 4, 2016
Since the introduction of direct-acting antivirals that in clinical trials demonstrated higher sustained virologic response (SVR) rates in hepatitis C patients than ever before, we’ve seen figures on sales, treatment costs, adherence levels, etc. For example, Harvoni (ledipasvir and sofosbuvir) and...

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?